Edition:
United States

People: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

49.90USD
29 Jul 2016
Change (% chg)

$1.77 (+3.68%)
Prev Close
$48.13
Open
$49.00
Day's High
$50.06
Day's Low
$48.28
Volume
1,435,697
Avg. Vol
1,133,870
52-wk High
$80.71
52-wk Low
$27.14

Pugh, Gordon 

Mr. Gordon G. Pugh is Chief Operating Officer, Senior Vice President, Chief Risk Officer of Alkermes Plc. Prior to assuming his current positions, Mr. Pugh served as Senior Vice President, Chief Operating Officer and Chief Risk Officer of Alkermes, Inc. Prior to assuming the Senior Vice President and Chief Operating Officer positions in May 2007 and the Chief Risk Officer position in July 2010, Mr. Pugh served as Vice President of Operations of Alkermes, Inc. Mr. Pugh has over 30 years of operations and manufacturing experience. For the eight-year period prior to joining Alkermes, Inc., Mr. Pugh worked at Lonza Biologics, Inc., a publicly traded life sciences company, as the Vice President of manufacturing operations in the United States and Europe. Mr. Pugh has served on the board of directors of KC Bio LLC, a privately held company, since 2000.

Basic Compensation

Total Annual Compensation, USD 437,493
Restricted Stock Awards, USD 271,575
Long-Term Incentive Plans, USD --
All Other, USD 1,256,660
Fiscal Year Total, USD 1,965,720

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 69,550 697,862.00
Name Fiscal Year Total

Richard Pops

10,448,400

Shane Cooke

4,646,970

James Frates

2,565,400

Gordon Pugh

1,965,720

Kathryn Biberstein

3,041,000

Elliot Ehrich

3,188,760
As Of  30 Dec 2014